Compare Sana Biotechnology Inc (SANA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Sana Biotechnology Inc trades at $2.34 (market cap $697.51M), while Vir Biotechnology Inc. Common Stock trades at $10.5 (market cap $1.76B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 2.5× Sana Biotechnology Inc's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 24 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SANA | VIR | |
|---|---|---|
Market Cap | $697.51M | $1.76B |
Volume | 2,763,583 | 2,764,948 |
Sector | Health | Health |
52-Week High | $5.92 | $11.78 |
52-Week Low | $2.33 | $5.12 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $610.76M | $1.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
